BCL2 and B-cell chronic lymphocytic leukemia: In addition to the acquired resistance directly linked to changes in the BCL-2 family, Herling et al. have recently reported other potential mechanisms through whole-exome sequencing of serial samples from CLL patients treated with venetoclax [43].